A Smart Nanoparticle-Laden and Remote-Controlled Self-Destructive Macrophage for Enhanced Chemo/Chemodynamic Synergistic Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32955858.
- Also identified by DOI 10.1021/acsnano.0c06290.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Macrophages are known to penetrate tumor central hypoxic areas and hold great potential in cancer drug delivery. However, it remains a big challenge for current macrophage-based drug delivery systems (MDDSs) to prevent premature drug leakage and sufficiently release the therapeutics in tumor sites. Moreover, these MDDSs would encounter drug resistance and a hypoxic microenvironment in solid tumors, which further compromised their therapeutic efficacy. Herein, by internalizing a smart nanoparticle (doxorubicin (DOX)-loaded mesoporous carbon nanosphere wrapped with MnO<sub>2</sub> shell) into macrophages, a macrophage vehicle (MMDM) is developed for enhanced chemo/chemodynamic synergistic therapy. The resulting MMDM could avoid premature drug leakage-induced cell dysfunction and maximally maintain cell viability. After accumulating in tumor tissues, the MMDM could be destroyed under a near-infrared laser to sufficiently release the nanoparticle out of the carrier macrophages. The released nanoparticle could then decompose H<sub>2</sub>O<sub>2</sub> to generate O<sub>2</sub> in the tumor microenvironment to relieve tumor hypoxia. Meanwhile, the MnO<sub>2</sub> shell of the nanoparticle is reduced to Mn<sup>2+</sup> by intracellular glutathione, triggering the release of DOX and subsequently resulting in an enhanced Mn<sup>2+</sup>-mediated Fenton-like reaction. This study provides an intriguing strategy to macrophage-based delivery systems for enhanced chemo/chemodynamic synergistic therapy.
Medical subject headings
- Manganese Compounds
- Nanoparticles